| 22/06/23 | 07:00:03 | 22 Jun 2023 | | Oral Vaccine Programme Moves Forward | RNS |
| 24/05/23 | 07:00:14 | 24 May 2023 | | Board Appointment | RNS |
| 11/05/23 | 14:27:09 | 11 May 2023 | | Results of Annual General Meeting | RNS |
| 12/04/23 | 07:00:06 | 12 Apr 2023 | | Annual Report & AGM Notice | RNS |
| 30/03/23 | 07:00:05 | 30 Mar 2023 | | Results for the year ended 31 December 2022 | RNS |
| 10/03/23 | 07:00:07 | 10 Mar 2023 | | Notification of Major Holdings | RNS |
| 09/03/23 | 15:51:42 | 9 Mar 2023 | | Notification of Major Holdings | RNS |
| 08/03/23 | 07:00:06 | 8 Mar 2023 | | POLB 001 patent portfolio strengthened | RNS |
| 02/03/23 | 11:05:38 | 2 Mar 2023 | | Second Price Monitoring Extn | RNS |
| 02/03/23 | 11:00:32 | 2 Mar 2023 | | Price Monitoring Extension | RNS |
| 02/03/23 | 07:00:08 | 2 Mar 2023 | | Positive Results POLB001 LPS Human Challenge Trial | RNS |
| 16/01/23 | 07:00:05 | 16 Jan 2023 | | Strategic expansion of POLB 001 into oncology | RNS |
| 09/01/23 | 09:05:50 | 9 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 09/01/23 | 09:00:36 | 9 Jan 2023 | | Price Monitoring Extension | RNS |
| 09/01/23 | 07:00:02 | 9 Jan 2023 | | Positive Initial Data Analysis in POLB 001 Trial | RNS |
| 21/12/22 | 07:00:05 | 21 Dec 2022 | | Poolbeg identifies novel RSV drug candidates | RNS |
| 14/12/22 | 07:00:04 | 14 Dec 2022 | | Metabolic diseases oral delivery licence signed | RNS |
| 12/12/22 | 14:05:35 | 12 Dec 2022 | | Second Price Monitoring Extn | RNS |
| 12/12/22 | 14:00:30 | 12 Dec 2022 | | Price Monitoring Extension | RNS |
| 12/12/22 | 07:00:03 | 12 Dec 2022 | | POLB 001 LPS human challenge trial completed | RNS |
| 29/11/22 | 07:00:08 | 29 Nov 2022 | | Influenza AI model build completed | RNS |
| 18/11/22 | 14:00:48 | 18 Nov 2022 | | Price Monitoring Extension | RNS |
| 17/11/22 | 14:05:57 | 17 Nov 2022 | | Second Price Monitoring Extn | RNS |
| 17/11/22 | 14:00:33 | 17 Nov 2022 | | Price Monitoring Extension | RNS |
| 17/11/22 | 07:00:07 | 17 Nov 2022 | | Capital Markets Day | RNS |
| 15/11/22 | 10:36:28 | 15 Nov 2022 | | Poolbeg-led consortium awarded EUR 2.3m grant | RNS |
| 08/11/22 | 07:00:04 | 8 Nov 2022 | | AI programme yields novel RSV drug targets | RNS |
| 21/10/22 | 07:00:03 | 21 Oct 2022 | | Upcoming events participation | RNS |
| 06/10/22 | 16:40:57 | 6 Oct 2022 | | Second Price Monitoring Extn | RNS |
| 06/10/22 | 16:35:53 | 6 Oct 2022 | | Price Monitoring Extension | RNS |
| 06/10/22 | 07:00:09 | 6 Oct 2022 | | CEO Share Purchase | RNS |
| 04/10/22 | 07:00:05 | 4 Oct 2022 | | POLB 001 US Patent update | RNS |
| 21/09/22 | 07:00:03 | 21 Sept 2022 | | Poolbeg licence of Melioidosis vaccine candidate | RNS |
| 12/09/22 | 07:00:08 | 12 Sept 2022 | | HC Wainwright Global Investment Conference | RNS |
| 06/09/22 | 14:05:59 | 6 Sept 2022 | | Second Price Monitoring Extn | RNS |
| 06/09/22 | 14:00:53 | 6 Sept 2022 | | Price Monitoring Extension | RNS |
| 06/09/22 | 07:00:13 | 6 Sept 2022 | | Interim Results | RNS |
| 31/08/22 | 07:25:49 | 31 Aug 2022 | | Notice of Results | RNS |
| 29/07/22 | 07:00:11 | 29 Jul 2022 | | Appointment of Joint Broker | RNS |
| 20/07/22 | 07:00:06 | 20 Jul 2022 | | POLB001 human challenge clinical trial to commence | RNS |
| 12/07/22 | 14:06:01 | 12 Jul 2022 | | Second Price Monitoring Extn | RNS |
| 12/07/22 | 14:00:34 | 12 Jul 2022 | | Price Monitoring Extension | RNS |
| 27/06/22 | 07:00:05 | 27 Jun 2022 | | Project update for AI model of RSV data | RNS |
| 21/06/22 | 16:40:47 | 21 Jun 2022 | | Second Price Monitoring Extn | RNS |
| 21/06/22 | 16:36:08 | 21 Jun 2022 | | Price Monitoring Extension | RNS |
| 26/05/22 | 14:05:50 | 26 May 2022 | | Second Price Monitoring Extn | RNS |
| 26/05/22 | 14:00:25 | 26 May 2022 | | Price Monitoring Extension | RNS |
| 26/05/22 | 07:00:07 | 26 May 2022 | | US patents granted for POLB 001 and POLB 002 | RNS |
| 25/05/22 | 16:40:36 | 25 May 2022 | | Second Price Monitoring Extn | RNS |
| 25/05/22 | 16:35:27 | 25 May 2022 | | Price Monitoring Extension | RNS |
